March 18, 2024 |
We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met. The best of both worlds. In the era of digital transformation, it is predicted that 2024 will be the year that finally cements hybrid meetings as the norm (1), with all-virtual meetings continuing to be a popular option. Yet, some people are holding onto the idea of in-person meetings being superior. In this article, we’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put this idea to rest.
I’ve written and talked about the blindspots of in-person meetings for over 16 years now, but it’s only been in the past few years that the benefits of virtual engagements have gained mainstream acceptance. There are multiple reasons why in-person-only meetings should be laid to rest, including, but not limited to, the facts that they are:
Specifically for advisory boards and other insight-gathering initiatives, the in-person-only approach comes with additional pain points such as:
Most important, though, is the fact that participants don’t want only in-person meetings. Based on our survey of hundreds of healthcare provider advisors in 2022–2023, over three-quarters stated that they prefer virtual/hybrid meetings, with the convenience and flexibility of digital meetings rated as the top benefits…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Aaron Leibtag, CEO & Co-Founder of Pentavere Research Group, discusses his transition from being an Organizational Transformation Leader to co-founding a startup focused on healthcare technology. We also dive into how…
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE.
Randi Goeckeler, Global Stakeholder Relations & Strategic Engagement Leadership Expert, discusses some of the key lessons she has learned from the various roles she has held at top pharma companies….
Eugene Borukhovich, Chairman & COO of YourCoach.Health, discusses his transition from Global Head of Digital Health at Bayer to full-time entrepreneur. We also talk about YourCoach’s mission, the impact of COVID-19…
Scott Phillips, President at StarFish Medical, shares his ongoing work to empower MedTech innovation in Canada and overseas. We also discuss how COVID-19 has impacted the MedTech industry and the many…
Leon Eisen, Chief Executive Officer of Oxitone, talks about “remote continuous care”, the role of AI-powered predictive analytics and alerts in providing this type of care. We also explore how Oxitone…
Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. We also explore questions such as how AI and “intelligent matchmaking” can be…
Tushar Pant, Consulting Executive in Healthcare at IBM, discusses how technology is transforming healthcare. Among many other things, we explore how IBM is working to improve the healthcare industry in Canada,…
Yianni Serpanos, Founder & CEO of HealthTechX, discusses a variety of topics, including how COVID-19 has affected the uptake of telehealth among allied health professionals in Australia and worldwide. Yianni also…
